Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the U.S. Food and Drug Administration to take action against “bad actors” selling counterfeit weight loss drugs.

Apple's and Eli Lilly's plans to expand manufacturing and development in the U.S. Earning updates from Home Depot and Cava.

Consumers who use telehealth or medical spas to get less expensive, compounded weight loss drugs will need to get their medications elsewhere.

AbbVie's strategic move into the obesity market through a partnership with Gubra A/S shows potential but won't impact revenue ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the ...

Four Colorado physicians are named in a lawsuit settlement involving pharmaceutical company Biohaven, which allegedly paid ...

As weight loss drugs continue to grow in popularity in the U.S., some health leaders are warning about fake drugs on the ...

China, India and the US will have the world’s largest populations of adults living with overweight and obesity by 2050, according to new research that highlights the global public health crisis and ...

With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.

Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...

They say war is hell - and it looks like millions of American men are about to learn this the hard way (or maybe not exactly ...

It's the second year in a row that Lilly has used the Oscars as a platform to drive home a message about GLP-1-based obesity ...